Published in Biotech Business Week, January 3rd, 2005
The invention is the result of PURE's research and development program, headed by Andrew B. Arata, PURE's director of Bioscience Research and Development and inventor of SDC, to maximize its novel ionic silver antimicrobial technologies. Current patents cover PURE's aqueous, or liquid, silver dihydrogen citrate (SDC).
The new patent expands the protected technologies to include solid compositions of this unique antimicrobial that may be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.